• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过核糖体展示技术开发新型抗HER2单链抗体片段,并对其三维结构以及与HER2单独结合和与LAMP2B融合后结合情况进行计算机模拟评估。

Development of a novel anti-HER2 scFv by ribosome display and in silico evaluation of its 3D structure and interaction with HER2, alone and after fusion to LAMP2B.

作者信息

Salimi Fatemeh, Forouzandeh Moghadam Mehdi, Rajabibazl Masoumeh

机构信息

Department of Medical Biotechnology, Faculty of Medical Sciences, Tarbiat Modares University, Nasr Bridge, P.O. Box 14115-331, Tehran, Iran.

Department of Clinical Biochemistry, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

出版信息

Mol Biol Rep. 2018 Dec;45(6):2247-2256. doi: 10.1007/s11033-018-4386-2. Epub 2018 Sep 17.

DOI:10.1007/s11033-018-4386-2
PMID:30225583
Abstract

HER2 is a member of epidermal factor receptor (EGFR) family which is overexpressed in breast cancer, ovarian cancer and gastric cancer. Development of new binders for cancer cell surface receptors and expressing them at the surface of exosomes would be a great approach in targeted cancer therapy. We found a high affinity scFv against HER2 using ribosome display with the approach of applying it as a targeting moiety at the surface of exosomes by fusion to lysosomal associated membrane protein 2B (LAMP2B). We also provide some structural information about the ribosome display selected scFv (scFv HFS2) through modeling the 3D structure of scFv HFS2 using RosettaAntibody and docked it at the extracellular domain of HER2. We also evaluated the structure of scFv HFS2 and its binding to HER2 after fusion to LAMP2B. Our results showed no significant change in 3D structure of scFv HFS2 when fused to LAMP2B (RMSD 1.3) and interaction analysis represented that scFv HFS2 binds HER2 domain III before and after fusion to LAMP2B. Although binding domain of scFv HFS2 on HER2 was the same at both state, residues involved in their interactions showed significant differences as it was probably due to the spatial hindrance of scFv HFS2 when fused to LAMP2B through a short linker and it should be considered before proceeding to experiment.

摘要

HER2是表皮生长因子受体(EGFR)家族的成员,在乳腺癌、卵巢癌和胃癌中过表达。开发针对癌细胞表面受体的新型结合物并将其在外泌体表面表达,将是靶向癌症治疗的一种很好的方法。我们通过核糖体展示技术找到了一种针对HER2的高亲和力单链抗体片段(scFv),并采用将其与溶酶体相关膜蛋白2B(LAMP2B)融合的方法,将其作为外泌体表面的靶向部分。我们还通过使用RosettaAntibody对scFv HFS2的三维结构进行建模,提供了一些关于核糖体展示筛选出的scFv(scFv HFS2)的结构信息,并将其对接至HER2的细胞外结构域。我们还评估了scFv HFS2与LAMP2B融合后的结构及其与HER2的结合情况。我们的结果表明,scFv HFS2与LAMP2B融合后其三维结构没有显著变化(均方根偏差为1.3),相互作用分析表明,scFv HFS2在与LAMP2B融合前后均与HER2结构域III结合。虽然scFv HFS2在HER2上的结合结构域在两种状态下是相同的,但参与相互作用的残基显示出显著差异,这可能是由于scFv HFS2通过短连接子与LAMP2B融合时的空间位阻所致,在进行实验之前应予以考虑。

相似文献

1
Development of a novel anti-HER2 scFv by ribosome display and in silico evaluation of its 3D structure and interaction with HER2, alone and after fusion to LAMP2B.通过核糖体展示技术开发新型抗HER2单链抗体片段,并对其三维结构以及与HER2单独结合和与LAMP2B融合后结合情况进行计算机模拟评估。
Mol Biol Rep. 2018 Dec;45(6):2247-2256. doi: 10.1007/s11033-018-4386-2. Epub 2018 Sep 17.
2
Highly efficient production of anti-HER2 scFv antibody variant for targeting breast cancer cells.高效生产靶向乳腺癌细胞的抗 HER2 scFv 抗体变体。
Appl Microbiol Biotechnol. 2011 Aug;91(3):613-21. doi: 10.1007/s00253-011-3306-3. Epub 2011 May 3.
3
Discovery of hapten-specific scFv from a phage display library and applications for HER2-positive tumor imaging.从噬菌体展示文库中发现半抗原特异性单链抗体片段及其在HER2阳性肿瘤成像中的应用。
Bioconjug Chem. 2014 Jul 16;25(7):1311-22. doi: 10.1021/bc500173f. Epub 2014 Jun 18.
4
Isolation and characterization of a novel GRP78-specific single-chain variable fragment (scFv) using ribosome display method.利用核糖体展示技术分离鉴定新型 GRP78 特异性单链抗体可变区片段。
Med Oncol. 2021 Aug 14;38(9):115. doi: 10.1007/s12032-021-01561-3.
5
Design and construction of scFv-PE35KDEL as a novel immunotoxin against human epidermal growth factor receptor 2 for cancer therapy.设计并构建单链抗体-PE35KDEL作为一种新型免疫毒素用于治疗癌症的人表皮生长因子受体2。
Biotechnol Lett. 2023 Apr;45(4):537-550. doi: 10.1007/s10529-023-03360-4. Epub 2023 Feb 20.
6
Targeted delivery of tumor antigens to activated dendritic cells via CD11c molecules induces potent antitumor immunity in mice.通过CD11c分子将肿瘤抗原靶向递送至活化的树突状细胞可在小鼠中诱导强大的抗肿瘤免疫。
Clin Cancer Res. 2009 Jul 15;15(14):4612-21. doi: 10.1158/1078-0432.CCR-08-3321. Epub 2009 Jul 7.
7
[Immunocytochemical visualization of P185(HER2) receptor by antibody fused with dibarnase and conjugate of barstar with colloidal gold].[通过与双核糖核酸酶融合的抗体及巴氏杆菌抑制因子与胶体金的缀合物对P185(HER2)受体进行免疫细胞化学可视化]
Mol Biol (Mosk). 2013 Sep-Oct;47(5):806-17.
8
Reduced Tumor Volume and Increased Necrosis of Human Breast Tumor Xenograft in Mice Pretreated by a Cocktail of Three Specific Anti-HER2 scFvs.用三种特定抗 HER2 scFv 鸡尾酒预处理的荷人乳腺癌异种移植瘤小鼠的肿瘤体积缩小和坏死增加。
Curr Protein Pept Sci. 2024;25(5):409-418. doi: 10.2174/0113892037269645231031095145.
9
Improved biological activity of a single chain antibody fragment against human epidermal growth factor receptor 2 (HER2) expressed in the periplasm of Escherichia coli.在大肠杆菌周质中表达的抗人表皮生长因子受体2(HER2)单链抗体片段的生物学活性得到改善。
Protein Expr Purif. 2015 Dec;116:66-74. doi: 10.1016/j.pep.2015.07.005. Epub 2015 Jul 10.
10
Anti-HER2 scFv Expression in Escherichia coli SHuffleT7 Express Cells: Effects on Solubility and Biological Activity.抗 HER2 scFv 在大肠杆菌 SHuffleT7 Express 细胞中的表达:对可溶性和生物学活性的影响。
Mol Biotechnol. 2020 Jan;62(1):18-30. doi: 10.1007/s12033-019-00221-2.

引用本文的文献

1
Engineered exosomes: a promising drug delivery platform with therapeutic potential.工程化外泌体:一个具有治疗潜力的有前景的药物递送平台。
Front Mol Biosci. 2025 May 9;12:1583992. doi: 10.3389/fmolb.2025.1583992. eCollection 2025.
2
Strategies to functionalize extracellular vesicles against HER2 for anticancer activity.使细胞外囊泡针对HER2进行功能化以实现抗癌活性的策略。
Extracell Vesicles Circ Nucl Acids. 2022 Apr 18;3(2):93-101. doi: 10.20517/evcna.2022.07. eCollection 2022.
3
Production of a Ribosome-Displayed Mouse scFv Antibody Against CD133, Analysis of Its Molecular Docking, and Molecular Dynamic Simulations of Their Interactions.

本文引用的文献

1
Targeted cancer therapy using engineered exosome as a natural drug delivery vehicle.使用工程化外泌体作为天然药物递送载体的靶向癌症治疗。
Onco Targets Ther. 2018 Sep 12;11:5753-5762. doi: 10.2147/OTT.S173110. eCollection 2018.
2
Engineered Exosomes for Targeted Transfer of siRNA to HER2 Positive Breast Cancer Cells.工程化外泌体用于靶向转染 HER2 阳性乳腺癌细胞的 siRNA。
Appl Biochem Biotechnol. 2019 Jan;187(1):352-364. doi: 10.1007/s12010-018-2813-4. Epub 2018 Jun 28.
3
Modeling and docking of antibody structures with Rosetta.
核糖体展示技术筛选抗 CD133 单链抗体及其分子对接和分子动力学模拟分析
Appl Biochem Biotechnol. 2024 Mar;196(3):1399-1418. doi: 10.1007/s12010-023-04609-4. Epub 2023 Jul 6.
4
Characteristic of molecular subtype based on lysosome-associated genes reveals clinical prognosis and immune infiltration of gastric cancer.基于溶酶体相关基因的分子亚型特征揭示胃癌的临床预后和免疫浸润
Front Oncol. 2023 May 1;13:1155418. doi: 10.3389/fonc.2023.1155418. eCollection 2023.
5
Computational discovery of binding mode of anti-TRBC1 antibody and predicted key amino acids of TRBC1.抗 TRBC1 抗体结合模式的计算发现及 TRBC1 的预测关键氨基酸。
Sci Rep. 2022 Feb 2;12(1):1760. doi: 10.1038/s41598-022-05742-6.
6
Expedition into Exosome Biology: A Perspective of Progress from Discovery to Therapeutic Development.外泌体生物学探索:从发现到治疗开发的进展视角
Cancers (Basel). 2021 Mar 8;13(5):1157. doi: 10.3390/cancers13051157.
抗体结构的建模与对接 Rosetta 方法。
Nat Protoc. 2017 Feb;12(2):401-416. doi: 10.1038/nprot.2016.180. Epub 2017 Jan 26.
4
Accurate Structure Prediction of CDR H3 Loops Enabled by a Novel Structure-Based C-Terminal Constraint.基于新型结构的C端约束实现CDR H3环的精确结构预测。
J Immunol. 2017 Jan 1;198(1):505-515. doi: 10.4049/jimmunol.1601137. Epub 2016 Nov 21.
5
3Drefine: an interactive web server for efficient protein structure refinement.3Drefine:一个用于高效蛋白质结构优化的交互式网络服务器。
Nucleic Acids Res. 2016 Jul 8;44(W1):W406-9. doi: 10.1093/nar/gkw336. Epub 2016 Apr 29.
6
Selection of Single Chain Antibody Fragments for Targeting Prostate Specific Membrane Antigen: A Comparison Between Cell-based and Antigen-based Approach.用于靶向前列腺特异性膜抗原的单链抗体片段的筛选:基于细胞和基于抗原方法的比较
Protein Pept Lett. 2016;23(4):336-42. doi: 10.2174/0929866523666160115131403.
7
The HADDOCK2.2 Web Server: User-Friendly Integrative Modeling of Biomolecular Complexes.HADDOCK2.2 网页服务器:生物分子复合物的用户友好型综合建模
J Mol Biol. 2016 Feb 22;428(4):720-725. doi: 10.1016/j.jmb.2015.09.014. Epub 2015 Sep 26.
8
Directed evolution of anti-HER2 DARPins by SNAP display reveals stability/function trade-offs in the selection process.通过SNAP展示对抗HER2亲环素设计的锚蛋白进行定向进化揭示了筛选过程中的稳定性/功能权衡。
Protein Eng Des Sel. 2015 Sep;28(9):269-79. doi: 10.1093/protein/gzv029. Epub 2015 Jun 30.
9
Assessing the local structural quality of transmembrane protein models using statistical potentials (QMEANBrane).使用统计势(QMEANBrane)评估跨膜蛋白模型的局部结构质量。
Bioinformatics. 2014 Sep 1;30(17):i505-11. doi: 10.1093/bioinformatics/btu457.
10
Insights into HER2 signaling from step-by-step optimization of anti-HER2 antibodies.从抗HER2抗体的逐步优化中洞察HER2信号传导
MAbs. 2014 Jul-Aug;6(4):978-90. doi: 10.4161/mabs.28786. Epub 2014 Apr 16.